scholarly article | Q13442814 |
P2093 | author name string | G Kaplan | |
P Thompson | |||
G. Kaplan | |||
S M Feinstone | |||
S. M. Feinstone | |||
Y. Moritsugu | |||
A Totsuka | |||
A. Totsuka | |||
P. Thompson | |||
T Akatsuka | |||
T. Akatsuka | |||
Y Moritsugu | |||
P2860 | cites work | Genetic relatedness of hepatitis A virus strains recovered from different geographical regions | Q44739634 |
Identification of virus components in circulating immune complexes isolated during hepatitis a virus infection | Q45168527 | ||
Isolation of Hepatitis A Virus in Vitro in Cell Culture Directly from Human Specimens | Q45802167 | ||
Virus-binding activity of fibronectin: Masking of hepatitis A virus | Q45807658 | ||
Study of the chemical nature of Frp/3 cell recognition units for hepatitis A virus | Q45835243 | ||
Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions | Q45837943 | ||
Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. | Q46242630 | ||
An unusually small gene encoding a putative mucin-like glycoprotein in Trypanosoma cruzi | Q48084243 | ||
Variants of a Leishmania surface antigen derived from a multigenic family | Q48194582 | ||
A new repetitive protein from Xenopus laevis skin highly homologous to pancreatic spasmolytic polypeptide | Q48321273 | ||
DNA sequences, gene regulation and modular protein evolution in the Drosophila 68C glue gene cluster | Q48396741 | ||
Glue protein genes in Drosophila virilis: their organization, developmental control of transcription and specific mRNA degradation. | Q52242319 | ||
Appearance of immune complexes during experimental hepatitis A infection in chimpanzees. | Q52848657 | ||
Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site | Q70110352 | ||
DNA sequencing with chain-terminating inhibitors | Q22066207 | ||
Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5) | Q24305334 | ||
Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method | Q24306280 | ||
Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure | Q24609771 | ||
Basic local alignment search tool | Q25938991 | ||
A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells | Q27486246 | ||
A new method for predicting signal sequence cleavage sites | Q27861117 | ||
The AGA1 product is involved in cell surface attachment of the Saccharomyces cerevisiae cell adhesion glycoprotein a-agglutinin | Q27934510 | ||
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system | Q29614579 | ||
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain | Q30794103 | ||
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid | Q34176666 | ||
Mucins: structure, function, and associations with malignancy | Q35284163 | ||
The core polypeptide of cystic fibrosis tracheal mucin contains a tandem repeat structure. Evidence for a common mucin in airway and gastrointestinal tissue | Q35817447 | ||
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage | Q36423193 | ||
Mucin-Type Glycoproteins | Q36727757 | ||
Expression of MUC2 gene is down-regulated by vitamin A at the transcriptional level in vitro in tracheobronchial epithelial cells | Q36749697 | ||
Isolation and characterization of HeLa cell lines blocked at different steps in the poliovirus life cycle | Q36779930 | ||
A cluster type organization of the loci of the immunoglobulin light chain in Atlantic cod (Gadus morhua L.) and rainbow trout (Oncorhynchus mykiss Walbaum) indicated by nucleotide sequences of cDNAs and hybridization analysis | Q36784237 | ||
Restricted replication of hepatitis A virus in cell culture: encapsidation of viral RNA depletes the pool of RNA available for replication | Q36882021 | ||
Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. | Q36919141 | ||
Why are proteins O-glycosylated? | Q37951273 | ||
Targeting of oncoproteins to membranes by fatty acylation. | Q38261613 | ||
Susceptibility of nonprimate cell lines to hepatitis A virus infection. | Q40041641 | ||
MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism | Q40341956 | ||
Hepatitis A Virus Attachment to Cultured Cell Lines | Q41655989 | ||
Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines | Q41678219 | ||
Simian hepatitis A virus (HAV) strain AGM-27: comparison of genome structure and growth in cell culture with other HAV strains | Q42613256 | ||
Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. | Q42800845 | ||
Monoclonal antibodies against an immunodominant and neutralizing epitope on hepatitis A virus antigen | Q43939582 | ||
The use of sodium dodecyl sulfate in studies on the interaction of poliovirus and HeLa cells | Q44193884 | ||
P-domains as shuffled cysteine-rich modules in integumentary mucin C.1 (FIM-C.1) from Xenopus laevis. Polydispersity and genetic polymorphism | Q44628438 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis A | Q157661 |
Hepatitis A virus | Q4112120 | ||
P304 | page(s) | 4282-4296 | |
P577 | publication date | 1996-08-01 | |
P1433 | published in | The EMBO Journal | Q1278554 |
P1476 | title | Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus | |
P478 | volume | 15 |
Q28394353 | 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: farm lifestyles and the hygiene hypothesis |
Q56889692 | A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity |
Q40180287 | A polymorphism of the TIM-1 IgV domain: implications for the susceptibility to filovirus infection. |
Q27677825 | A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71 |
Q36171790 | A single mutation in the glycophorin A binding site of hepatitis A virus enhances virus clearance from the blood and results in a lower fitness variant |
Q35218397 | Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions |
Q34038950 | Animal virus receptors |
Q34028652 | Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma. |
Q28389278 | Apoptotic cells activate NKT cells through T cell Ig-like mucin-like-1 resulting in airway hyperreactivity |
Q39376854 | Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans |
Q28394172 | Capsid and Infectivity in Virus Detection |
Q39742810 | Capsid functions of inactivated human picornaviruses and feline calicivirus |
Q24563092 | Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane |
Q33850097 | Cell adhesion molecules in the pathogenesis of and host defence against microbial infection |
Q64104443 | Cellular entry and uncoating of naked and quasi-enveloped human hepatoviruses |
Q33781995 | Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein |
Q30409350 | Characterizing functional domains for TIM-mediated enveloped virus entry |
Q28281970 | Ciliary calcium signaling is modulated by kidney injury molecule-1 (Kim1) |
Q37348057 | Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium |
Q47555918 | Determinants in the IgV Domain of human HAVCR1 (TIM-1) are required to enhance Hepatitis C Virus Entry. |
Q40156757 | Differential binding of the HIV-1 envelope to phosphatidylserine receptors |
Q36229490 | Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function |
Q36167228 | Distinct Trafficking of Cell Surface and Endosomal TIM-1 to the Immune Synapse |
Q26829452 | Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology |
Q35627059 | Evolution of cell recognition by viruses: a source of biological novelty with medical implications |
Q57038980 | Exosomes exploit the virus entry machinery and pathway to transmit IFN-α-induced antiviral activity |
Q40891739 | Expression and polymorphisms of T cell immunoglobulin domain and mucin domain protein-1 in thymoma with or without myasthenia gravis |
Q36902474 | Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery. |
Q33782587 | Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. |
Q39554454 | Fyn binds to and phosphorylates T cell immunoglobulin and mucin domain-1 (Tim-1). |
Q37148892 | G protein α12 (Gα12) is a negative regulator of kidney injury molecule-1-mediated efferocytosis |
Q28741998 | Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ε-toxin |
Q50043306 | HAVCR1 (CD365) and its mouse ortholog are functional hepatitis A virus (HAV) cellular receptors that mediate HAV infection |
Q92307514 | HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome |
Q58617983 | HAVCR1 expression might be a novel prognostic factor for gastric cancer |
Q35739135 | HAVCR1 gene haplotypes and infection by different viral hepatitis C virus genotypes |
Q59349774 | Hepatitis A Virus Genome Organization and Replication Strategy |
Q37455000 | Hepatitis A virus (HAV) packaging size limit |
Q27317117 | Hepatitis A virus and the origins of picornaviruses |
Q43125471 | Hepatitis A virus exhibits a structure unique among picornaviruses |
Q39597642 | Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor |
Q33930596 | Hepatitis A: old and new. |
Q38076136 | Host cell factors in filovirus entry: novel players, new insights |
Q36751612 | Immune regulation by the TIM gene family |
Q24672280 | Immunoglobulin A (IgA) is a natural ligand of hepatitis A virus cellular receptor 1 (HAVCR1), and the association of IgA with HAVCR1 enhances virus-receptor interactions |
Q58769278 | Induction and Suppression of Innate Antiviral Responses by Hepatitis A Virus |
Q100387986 | KIM-1/TIM-1 is a Receptor for SARS-CoV-2 in Lung and Kidney |
Q44643853 | Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury |
Q37987860 | Living in the liver: hepatic infections |
Q39642336 | Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. |
Q38110735 | Molecular biology and inhibitors of hepatitis A virus |
Q39601471 | Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1. |
Q42154142 | Participation of T cell immunoglobulin and mucin domain-3 (TIM-3) and its ligand (galectin-9) in the pathogenesis of active generalized vitiligo |
Q41619024 | Picornaviruses |
Q39582731 | Polymorphisms of the hepatitis A virus cellular receptor 1 in African green monkey kidney cells result in antigenic variants that do not react with protective monoclonal antibody 190/4. |
Q37612504 | Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site |
Q64287366 | Prognostic value of TIM-1 expression in human non-small-cell lung cancer |
Q34017074 | Regulation of T cell responses by the receptor molecule Tim-3. |
Q42712237 | Regulation of T-cell immunity by T-cell immunoglobulin and mucin domain proteins |
Q92050905 | Reply to Das et al., "TIM1 (HAVCR1): an Essential 'Receptor' or an 'Accessory Attachment Factor' for Hepatitis A Virus?" |
Q40109827 | Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells |
Q37036794 | Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. |
Q27649330 | Structures of T Cell Immunoglobulin Mucin Protein 4 Show a Metal-Ion-Dependent Ligand Binding Site where Phosphatidylserine Binds |
Q27644081 | Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family |
Q37702049 | T cell Ig and mucin domain proteins and immunity |
Q37156795 | TIM family proteins promote the lysosomal degradation of the nuclear receptor NUR77. |
Q37763998 | TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity |
Q26995234 | TIM polymorphisms--genetics and function |
Q90461580 | TIM-1 As a Signal Receptor Triggers Dengue Virus-Induced Autophagy |
Q59350874 | TIM-1 Promotes Japanese Encephalitis Virus Entry and Infection |
Q36953538 | TIM-1 and TIM-3 proteins in immune regulation. |
Q28249050 | TIM-1, a novel allergy and asthma susceptibility gene |
Q34144143 | TIM-family proteins inhibit HIV-1 release. |
Q21131381 | TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine |
Q40056899 | TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions |
Q92050895 | TIM1 (HAVCR1): an Essential "Receptor" or an "Accessory Attachment Factor" for Hepatitis A Virus? |
Q28591447 | TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury |
Q42287215 | TIMs: central regulators of immune responses |
Q36503856 | Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation. |
Q24523091 | The Cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4 |
Q56988192 | The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral Strategies |
Q28272863 | The RSV fusion receptor: not what everyone expected it to be |
Q34695385 | The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury |
Q37962258 | The cell biology of receptor-mediated virus entry |
Q37474954 | The costimulatory role of TIM molecules |
Q24523454 | The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor |
Q37417681 | The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture |
Q37465998 | The role of T cell immunoglobulin mucin domains 1 and 4 in a herpes simplex virus-induced Behçet's disease mouse model |
Q38041099 | The role of TIM-containing molecules in airway disease and their potential as therapeutic targets |
Q41586462 | The role of cellular adhesion molecules in virus attachment and entry |
Q36961031 | The role of the T-cell costimulatory molecule Tim-1 in the immune response. |
Q39867601 | Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response. |
Q35084636 | Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells |
Q33220331 | Tim-2 regulates T helper type 2 responses and autoimmunity |
Q59789803 | Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1 regulatory B cell expansion |
Q64085335 | Understanding kidney injury molecule 1: a novel immune factor in kidney pathophysiology |
Q36845875 | Vectorial entry and release of hepatitis A virus in polarized human hepatocytes |
Q38520018 | Viral apoptotic mimicry |
Q27013917 | Viral quasispecies evolution |
Search more.